Literature DB >> 35896424

Chronic loss of muscarinic M5 receptor function manifests disparate impairments in exploratory behavior in male and female mice despite common dopamine regulation.

John A Razidlo1,2, Skylar M L Fausner1,2, Anna E Ingebretson1,2, Liuchang C Wang1,2, Christopher M Petersen1,2, Salahudeen Mirza1,2, Isabella N Swank, Veronica A Alvarez3, Julia C Lemos4,2.   

Abstract

There are five cloned muscarinic acetylcholine receptors (M1-M5). Of these, the muscarinic type 5 receptor (M5) is the only one localized to dopamine neurons in the ventral tegmental area and substantia nigra. Unlike M1-M4, the M5 receptor has relatively restricted expression in the brain, making it an attractive therapeutic target. Here we performed an in-depth characterization of M5-dependent potentiation of dopamine transmission in the nucleus accumbens and accompanying exploratory behaviors in male and female mice. We show that M5 receptors potentiate dopamine transmission by acting directly on the terminals within the nucleus accumbens. Using the muscarinic agonist oxotremorine, we revealed a unique concentration-response curve and a sensitivity to repeated forced swim stress or restraint stress exposure. We found that constitutive deletion of M5 receptors reduced exploration of the center of an open field while at the same time impairing normal habituation only in male mice. In addition, M5 deletion reduced exploration of salient stimuli, especially under conditions of high novelty, yet had no effect on hedonia assayed using the sucrose preference test or on stress coping strategy assayed using the forced swim test. We conclude that M5 receptors are critical for both engaging with the environment and updating behavioral output in response to environment cues, specifically in male mice. A cardinal feature of mood and anxiety disorders is withdrawal from the environment. These data indicate that boosting M5 receptor activity may be a useful therapeutic target for ameliorating these symptoms of depression and anxiety.Significance Statement:The basic physiological and behavioral functions of the muscarinic M5 receptor remain understudied. Furthermore, its presence on dopamine neurons, relatively restricted expression in the brain, and recent crystallization make it an attractive target for therapeutic development. Yet, most preclinical studies of M5 receptor function have primarily focused on substance use disorders in male rodents. Here we characterized the role of M5 receptors in potentiating dopamine transmission in the nucleus accumbens, finding impaired functioning after stress exposure. Furthermore, we show that M5 receptors can modulate exploratory behavior in a sex-specific manner, without impacting hedonic behavior. These findings further illustrate the therapeutic potential of the M5 receptor, warranting further research in the context of treating mood disorders.
Copyright © 2022 the authors.

Entities:  

Year:  2022        PMID: 35896424      PMCID: PMC9463982          DOI: 10.1523/JNEUROSCI.1424-21.2022

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.709


  56 in total

1.  Thalamic gating of corticostriatal signaling by cholinergic interneurons.

Authors:  Jun B Ding; Jaime N Guzman; Jayms D Peterson; Joshua A Goldberg; D James Surmeier
Journal:  Neuron       Date:  2010-07-29       Impact factor: 17.173

2.  Corticotropin-releasing factor in the nucleus accumbens shell induces swim depression, anxiety, and anhedonia along with changes in local dopamine/acetylcholine balance.

Authors:  Y-W Chen; P V Rada; B P Bützler; S F Leibowitz; B G Hoebel
Journal:  Neuroscience       Date:  2012-01-05       Impact factor: 3.590

3.  HCN2 Channels in Cholinergic Interneurons of Nucleus Accumbens Shell Regulate Depressive Behaviors.

Authors:  Jia Cheng; Gali Umschweif; Jenny Leung; Yotam Sagi; Paul Greengard
Journal:  Neuron       Date:  2019-01-10       Impact factor: 17.173

4.  Muscarinic, but not nicotinic, acetylcholine receptor blockade in the ventral tegmental area attenuates cue-induced sucrose-seeking.

Authors:  Nii A Addy; Eric J Nunes; Robert J Wickham
Journal:  Behav Brain Res       Date:  2015-05-28       Impact factor: 3.332

5.  Cholinergic Receptor Blockade in the VTA Attenuates Cue-Induced Cocaine-Seeking and Reverses the Anxiogenic Effects of Forced Abstinence.

Authors:  Eric J Nunes; Lillian Bitner; Shannon M Hughley; Keri M Small; Sofia N Walton; Laura E Rupprecht; Nii A Addy
Journal:  Neuroscience       Date:  2019-07-02       Impact factor: 3.590

Review 6.  The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review.

Authors:  Laetitia Prut; Catherine Belzung
Journal:  Eur J Pharmacol       Date:  2003-02-28       Impact factor: 4.432

7.  Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum.

Authors:  Sarah Threlfell; Michael A Clements; Tansi Khodai; Ilse S Pienaar; Richard Exley; Jürgen Wess; Stephanie J Cragg
Journal:  J Neurosci       Date:  2010-03-03       Impact factor: 6.167

8.  The thalamostriatal pathway and cholinergic control of goal-directed action: interlacing new with existing learning in the striatum.

Authors:  Laura A Bradfield; Jesus Bertran-Gonzalez; Billy Chieng; Bernard W Balleine
Journal:  Neuron       Date:  2013-06-13       Impact factor: 17.173

9.  Acetylcholine Receptor Stimulation Activates Protein Kinase C Mediated Internalization of the Dopamine Transporter.

Authors:  Suzanne M Underhill; Susan G Amara
Journal:  Front Cell Neurosci       Date:  2021-04-09       Impact factor: 5.505

Review 10.  Dopamine System Dysregulation in Major Depressive Disorders.

Authors:  Pauline Belujon; Anthony A Grace
Journal:  Int J Neuropsychopharmacol       Date:  2017-12-01       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.